Osteoclastogenic Differentiation of Macrophages in the Development of Abdominal Aortic Aneurysms

Yuichiro Takei1, Teruyoshi Tanaka1, K Craig Kent1

  • 1From the Division of Vascular Surgery, Department of Surgery, University of Wisconsin School of Medicine and Public Health, Madison.

Insights

Macrophages differentiate into bone-resorbing osteoclasts within aneurysmal arteries, driving disease progression. Inhibiting this process with bisphosphonate reduced aneurysm development in mice, suggesting a novel therapeutic target.

Area of Science:

  • Vascular Biology
  • Immunology
  • Bone Biology

Background:

  • Arterial calcification is a common contributor to occlusive vascular disease.
  • Bone remodeling involves a balance between osteogenesis and osteolysis.
  • The role of calcium homeostasis in aneurysm development remains unexplored.

Purpose of the Study:

  • To investigate the role of macrophage differentiation into osteoclasts in aneurysm pathophysiology.
  • To explore the contribution of protease byproducts to aneurysm development.

Main Methods:

  • Histological and immunohistochemical analyses of human aortic samples.
  • In situ zymography to assess protease activity.
  • Inhibition of osteoclastogenic differentiation using bisphosphonate in a mouse aneurysm model.

Main Results:

  • Macrophages expressing osteoclast markers were abundant in human aneurysmal aortas but scarce in stenotic or healthy aortas.
  • Elevated protease activity was observed in these macrophage-derived osteoclasts.
  • Tumor necrosis factor-α and calcium phosphate stimulated osteoclastogenic differentiation via specific signaling pathways.
  • Bisphosphonate treatment inhibited aneurysm development in a mouse model.

Conclusions:

  • Macrophage differentiation into osteoclasts is a key factor in aneurysm pathophysiology.
  • Targeting osteoclastogenic differentiation may offer a therapeutic strategy for aneurysmal disease.
Abstract